Category: PULMONARY

Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer

Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy — given before and after surgery — significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer(NSCLC),

Lung cancer study offers further evidence on importance of screening

Researchers from the University of Liverpool and Queen Mary University of London have published the first study in the UK to demonstrate the benefits of lung cancer screening across socioeconomic

Artificial intelligence blood test provides a reliable way to identify lung cancer

Using artificial intelligence technology to identify patterns of DNA fragments associated with lung cancer, researchers from the Johns Hopkins Kimmel Cancer Center and other institutions have developed and validated a

Why many lung cancer patients who have never smoked have worse outcomes

The reason why targeted treatment for non-small cell lung cancer fails to work for some patients, particularly those who have never smoked, has been discovered by researchers from UCL, the

Nano-immunotherapy developed to improve lung cancer treatment

Researchers at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, have developed a new nanomedicine therapy that delivers anticancer drugs to lung cancer cells

New study finds 40-percent of cancer cases and almost half of all deaths in the US linked to modifiable risk factors

A new study led by researchers at the American Cancer Society (ACS) finds four in 10 cancer cases and about one-half of all cancer deaths in adults 30 years old

Diabetes drug reduces drug resistance in lung cancer, improving chemotherapy effectiveness

A medication used to treat diabetic neuropathy may make chemotherapy treatments more effective for patients with lung cancer, according to new findings from the University of Missouri School of Medicine

Artificial intelligence improves lung cancer diagnosis

A team of researchers from the University of Cologne’s Faculty of Medicine and University Hospital Cologne, led by Dr Yuri Tolkach and Professor Dr Reinhard Büttner, has created a digital

New, rare type of small cell lung cancer identified

A team of doctors and researchers at Memorial Sloan Kettering Cancer Center (MSK) have identified a new, rare type of small cell lung cancer that primarily affects younger people who

Experimental mRNA cancer vaccine shows potential for advanced stage cancer patients in Phase 1 trial

Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers. The investigational mRNA cancer immunotherapy is targeted